牛牛AI助手已提取核心信息
Vertex Pharmaceuticals Inc. officer Bastiano Sanna is set to sell 3,002 shares of common stock on 02/21/2024, with an aggregate market value of $1,266,153.54. The shares were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Sanna, who has sold a total of 7,147 shares in the past three months, amounting to gross proceeds of $3,000,307.10. The notice of the planned sale was filed on the same day as the sale, with the plan for this transaction having been adopted on 08/25/2023.
Vertex Pharmaceuticals Inc. officer Bastiano Sanna is set to sell 3,002 shares of common stock on 02/21/2024, with an aggregate market value of $1,266,153.54. The shares were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Sanna, who has sold a total of 7,147 shares in the past three months, amounting to gross proceeds of $3,000,307.10. The notice of the planned sale was filed on the same day as the sale, with the plan for this transaction having been adopted on 08/25/2023.
Vertex Pharmicals Inc.高管巴斯蒂亚诺·桑纳定于2024年2月21日出售3,002股普通股，总市值为1,266,153.54美元。这些股票于2024年2月20日作为绩效股票收购，这是发行人的一种补偿形式。该交易遵循了Sanna最近的销售历史，该公司在过去三个月中共出售了7,147股股票，总收益为3,000,307.10美元。计划出售的通知是在出售的同一天提交的，该交易的计划已于2023年8月25日通过。
Vertex Pharmicals Inc.高管巴斯蒂亚诺·桑纳定于2024年2月21日出售3,002股普通股，总市值为1,266,153.54美元。这些股票于2024年2月20日作为绩效股票收购，这是发行人的一种补偿形式。该交易遵循了Sanna最近的销售历史，该公司在过去三个月中共出售了7,147股股票，总收益为3,000,307.10美元。计划出售的通知是在出售的同一天提交的，该交易的计划已于2023年8月25日通过。
有用
没用
该公告为独立文件：